Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human SECISBP2 Protein, N-His

Catalog #:   YHN31201 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q96T21
Protein length: Ser638-Leu854
Overview

Catalog No.

YHN31201

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser638-Leu854

Predicted molecular weight

26.71 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q96T21

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

SECISBP2, SECIS-binding protein 2, SBP2, Selenocysteine insertion sequence-binding protein 2

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human SECISBP2 protein
References

Understanding the role of tRNA modifications in UGA recoding as selenocysteine in eukaryotes., PMID:39988117

Severe neurodevelopmental phenotype, diagnostic, and treatment challenges in patients with SECISBP2 deficiency., PMID:39315526

Normal Values for the fT3/fT4 Ratio: Centile Charts (0-29 Years) and Their Application for the Differential Diagnosis of Children with Developmental Delay., PMID:39201272

Selenoprotein deficiency disorder predisposes to aortic aneurysm formation., PMID:38042913

Cell Differentiation Trajectory Predicts Prognosis and Immunotherapeutic Response in Clear Cell Renal Cell Carcinoma., PMID:36530957

High-Resolution Ribosome Profiling Reveals Gene-Specific Details of UGA Re-Coding in Selenoprotein Biosynthesis., PMID:36291713

Establishment and verification of a prognostic model of liver cancer by RNA-binding proteins based on the TCGA database., PMID:36249884

Structure of the mammalian ribosome as it decodes the selenocysteine UGA codon., PMID:35709277

Inherited Disorders of Thyroid Hormone Metabolism Defect Caused by the Dysregulation of Selenoprotein Expression., PMID:35126314

The emerging role of selenium metabolic pathways in cancer: New therapeutic targets for cancer., PMID:34935169

Human Genetic Disorders Resulting in Systemic Selenoprotein Deficiency., PMID:34884733

Identification of a novel endogenous long non-coding RNA that inhibits selenoprotein P translation., PMID:34142161

RNA-Associated Co-expression Network Identifies Novel Biomarkers for Digestive System Cancer., PMID:33841514

Potential relationship between the selenoproteome and cancer., PMID:33133596

SECISBP2 is a novel prognostic predictor that regulates selenoproteins in diffuse large B-cell lymphoma., PMID:33077808

Cardiac complications of thyroid hormone resistance syndromes., PMID:32513415

Identification of Resistance to Exogenous Thyroxine in Humans., PMID:32498666

Human Disorders Affecting the Selenocysteine Incorporation Pathway Cause Systemic Selenoprotein Deficiency., PMID:32295391

Clinical and Molecular Analysis in 2 Families With Novel Compound Heterozygous SBP2 (SECISBP2) Mutations., PMID:32084277

Role of the Thyroid Gland in Expression of the Thyroid Phenotype of Sbp2-Deficient Mice., PMID:31826256

Apparent resistance to thyroid hormones: From biological interference to genetics., PMID:31590893

Iodothyronine deiodinases and reduced sensitivity to thyroid hormones., PMID:31585886

Gained in translation: The power of digging deep into disease models., PMID:31562227

Ribosome profiling of selenoproteins in vivo reveals consequences of pathogenic Secisbp2 missense mutations., PMID:31350336

Functional Profiling Identifies Determinants of Arsenic Trioxide Cellular Toxicity., PMID:30815697

T-2 Toxin Induces Epiphyseal Plate Lesions via Decreased SECISBP2-Mediated Selenoprotein Expression in DA Rats, Exacerbated by Selenium Deficiency., PMID:30596260

The hsa-miR-181a-5p reduces oxidation resistance by controlling SECISBP2 in osteoarthritis., PMID:30286747

Selenium-sensitive miRNA-181a-5p targeting SBP2 regulates selenoproteins expression in cartilage., PMID:30247797

A Novel Homozygous Selenocysteine Insertion Sequence Binding Protein 2 (SECISBP2, SBP2) Gene Mutation in a Turkish Boy., PMID:29882503

Consequences of mutations and inborn errors of selenoprotein biosynthesis and functions., PMID:29709707

Identification of Genetic Disorders Causing Disruption of Selenoprotein Biosynthesis., PMID:28917055

In Vitro Translation Assays for Selenocysteine Insertion., PMID:28917039

Loss of selenocysteine insertion sequence binding protein 2 suppresses the proliferation, migration/invasion and hormone secretion of human trophoblast cells via the PI3K/Akt and ERK signaling pathway., PMID:28623977

SECIS-binding protein 2 interacts with the SMN complex and the methylosome for selenoprotein mRNP assembly and translation., PMID:28115638

The RNA-binding protein Secisbp2 differentially modulates UGA codon reassignment and RNA decay., PMID:27956496

Why 21? The significance of selenoproteins for human health revealed by inborn errors of metabolism., PMID:27473727

Targeted deletion of Secisbp2 reduces, but does not abrogate, selenoprotein expression and leads to striatal interneuron loss., PMID:26461424

Enhancement of lipid peroxidation and its amelioration by vitamin E in a subject with mutations in the SBP2 gene., PMID:26411970

Characterization of the UGA-recoding and SECIS-binding activities of SECIS-binding protein 2., PMID:25692238

Hypermethylated-capped selenoprotein mRNAs in mammals., PMID:25013170

The SBP2 protein central to selenoprotein synthesis contacts the human ribosome at expansion segment 7L of the 28S rRNA., PMID:24850884

Impaired selenoprotein expression in brain triggers striatal neuronal loss leading to co-ordination defects in mice., PMID:24844465

Inherited defects in thyroid hormone cell-membrane transport and metabolism., PMID:24629861

[Biosyinthesis and mechanism of selenocysteine incorporation into synthesized proteins]., PMID:24466745

Secisbp2 is essential for embryonic development and enhances selenoprotein expression., PMID:24274065

Different causes of reduced sensitivity to thyroid hormone: diagnosis and clinical management., PMID:23834164

A novel insight into the mechanism of mammalian selenoprotein synthesis., PMID:23788723

Identification of nucleotides and amino acids that mediate the interaction between ribosomal protein L30 and the SECIS element., PMID:23777426

The selenocysteine-specific elongation factor contains a novel and multi-functional domain., PMID:22992746

The syndromes of reduced sensitivity to thyroid hormone., PMID:22986150

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human SECISBP2 Protein, N-His [YHN31201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only